Media Speaks

Media Speaks

MRI-guided ultrasound relieves pain of bone metastases

An MRI-guided focused ultrasound approach using heat to alleviate the pain commonly associated with bone metastases has proven to be safe and effective in a multi-center phase III clinical trial, yielding a 64% response rate based on self-reported pain scores among patients receiving the noninvasive intervention. Read more


Focused ultrasound eases metastases pain

Bone metastases are common in patients with advanced cancer, causing severe pain and rapid degradation in quality of life. Such metastases are usually treated using radiation therapy, but this isn't suitable, or successful, for all patients. Now, an international research team has shown that there may be another option: MR-guided focused ultrasound (MRgFUS). Read more


MRI-guided focused ultrasound to treat pain from bone metastases

InSightec Ltd, the leader in magnetic resonance imaging guided Focused Ultrasound therapy (MRgFUS), announced that the results of its ExAblate® Phase III clinical trial for treating painful bone metastases have been published online in the JNCI, Journal of National Cancer Institute. Read more
 

Focused ultrasound reduces cancer pain

When cancer progresses and spreads to the bone, patients often suffer debilitating pain. Now, a new phase III clinical trial shows that non-invasive magnetic resonance guided focused ultrasound treatment that heats the cancer within the bone, relieves pain and improves function for most patients when other treatment options are limited. The results were published in the Journal of the National Cancer Institute (JNCI). Read more


A focused ultrasound can ‘reduce cancer pain

A non-invasive magnetic resonance guided focused ultrasound surgery (MRgFUS) heats the cancer that has spread to the bone, relieving pain and improving function for patients, according to new research published in the Journal of the National Cancer Institute. Read more
 

Focused ultrasound may relieve bone cancer pain

Focused ultrasound, guided by MRI, can noninvasively relieve pain for metastatic bone cancer patients, according to results of a clinical trial published online last month in the Journal of the National Cancer Institute.
The ultrasound destroys the cancer by heating it to a temperature of 65 to 85 degrees Celsius (150 to 185 degrees Fahrenheit). Real-time MRI monitors the temperature and precisely targets the ultrasound to avoid damage to adjoining healthy tissues. Read more